Novel Molecular Mechanisms of Dioctyl Phthalate‐Induced Pulmonary Fibrosis: Insights From Network Toxicology, Single‐Cell RNA Sequencing, and In Vitro Studies

Phthalate plasticizers have been implicated in respiratory diseases, but their role in idiopathic pulmonary fibrosis (IPF) pathogenesis remains unclear. This study employed an integrative approach combining network toxicology, bioinformatics, and experimental validation to investigate the impact of three common phthalates (PAEs) - diethyl phthalate (DEP), dimethyl phthalate (DMP), and dioctyl phthalate (DOP) - on pulmonary fibrosis pathogenesis. Network toxicology predicted DOP to be the most toxic of the three. By intersecting phthalate-related genes with IPF-associated differentially expressed genes from public datasets and applying bioinformatics analyses, we identified three core biomarkers: ALDH3A1, AVPR1A and GPBAR1, all of which had strong diagnostic value. Single-cell RNA sequencing revealed predominant GPBAR1 expression in macrophages and monocytes, with significant downregulation in IPF samples. Molecular docking and dynamics simulations predicted stable binding between DOP and GPBAR1. In vitro experiments confirmed that DOP exposure downregulated GPBAR1 in human alveolar macrophages, promoted the release of pro-inflammatory and pro-fibrotic cytokines, suppressed the expression of ribosomal proteins, and induced epithelial-mesenchymal transition (EMT) in co-cultured alveolar epithelial cells as well as fibroblast activation. Importantly, GPBAR1 overexpression attenuated these DOP-induced effects. This study identified GPBAR1 as the key PAE-associated biomarkers in IPF alveolar macrophages and suggested that DOP may exacerbate pulmonary fibrosis by promoting inflammation, EMT and fibroblast activation, potentially through GPBAR1 downregulation and subsequent ribosomal dysregulation in alveolar macrophages. Further in vivo investigations are required to validate these translational implications.

Authors

Institutions

Publication Details

Journal
The FASEB Journal
Published
2026-11-18
DOI
https://doi.org/10.1096/fj.202602992r
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Novel Molecular Mechanisms of Dioctyl Phthalate‐Induced Pulmonary Fibrosis: Insights From Network Toxicology, Single‐Cell RNA Sequencing, and In Vitro Studies

Diandian Li, Bo Wang, Yan Hou, Lian Liu et al.
4 links
The FASEB Journal
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Novel Molecular Mechanisms of Dioctyl Phthalate‐Induced Pulmonary Fibrosis: Insights From Network Toxicology, Single‐Cell RNA Sequencing, and In Vitro Studies

Diandian Li, Bo Wang, Yan Hou, Lian Liu, Jiangyue Qin
article en

Abstract

Phthalate plasticizers have been implicated in respiratory diseases, but their role in idiopathic pulmonary fibrosis (IPF) pathogenesis remains unclear. This study employed an integrative approach combining network toxicology, bioinformatics, and experimental validation to investigate the impact of three common phthalates (PAEs) - diethyl phthalate (DEP), dimethyl phthalate (DMP), and dioctyl phthalate (DOP) - on pulmonary fibrosis pathogenesis. Network toxicology predicted DOP to be the most toxic of the three. By intersecting phthalate-related genes with IPF-associated differentially expressed genes from public datasets and applying bioinformatics analyses, we identified three core biomarkers: ALDH3A1, AVPR1A and GPBAR1, all of which had strong diagnostic value. Single-cell RNA sequencing revealed predominant GPBAR1 expression in macrophages and monocytes, with significant downregulation in IPF samples. Molecular docking and dynamics simulations predicted stable binding between DOP and GPBAR1. In vitro experiments confirmed that DOP exposure downregulated GPBAR1 in human alveolar macrophages, promoted the release of pro-inflammatory and pro-fibrotic cytokines, suppressed the expression of ribosomal proteins, and induced epithelial-mesenchymal transition (EMT) in co-cultured alveolar epithelial cells as well as fibroblast activation. Importantly, GPBAR1 overexpression attenuated these DOP-induced effects. This study identified GPBAR1 as the key PAE-associated biomarkers in IPF alveolar macrophages and suggested that DOP may exacerbate pulmonary fibrosis by promoting inflammation, EMT and fibroblast activation, potentially through GPBAR1 downregulation and subsequent ribosomal dysregulation in alveolar macrophages. Further in vivo investigations are required to validate these translational implications.

The FASEB JournalVol. 40(22)
Sichuan University (CN), West China Medical Center of Sichuan University (CN), West China Hospital of Sichuan University (CN), Chinese People's Liberation Army (CN), State Key Laboratory of Biotherapy (CN)
National Natural Science Foundation of China, Key Research and Development Program of Sichuan Province
Good health and well-being
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon